Inflammatory Rhabdomyoblastic Tumor with Malignant Progression of the Neck: Unique Copy Number Profile Identified by Nanopore Sequencing
- 29 August 2026
- journal article
- case report
- Published by Springer Nature in Head and Neck Pathology
- Vol. 20 (1) , 94
Abstract
Inflammatory rhabdomyoblastic tumors (IRMT) are newly described entities characterized by a near-haploid karyotype. Most IRMTs exhibit indolent behavior; however, rare malignant transformation has been reported. We report a case of IRMT with malignant progression. Case Presentation A 67-year-old man presented with a painless mass in the left neck. Radiology revealed a 40-mm tumor in the left sternocleidomastoid muscle, with no evidence of distant metastasis. Results Core needle biopsy showed densely proliferating polygonal cells with pleomorphic nuclei, necrosis, and atypical mitoses. Based on histology, a preliminary diagnosis of pleomorphic rhabdomyosarcomas was made, although the clinical behavior seemed atypical. Nanopore DNA sequencing was subsequently performed and, within days, revealed characteristic molecular features, including relative gains of chromosomes 5, 7, and 22, a TP53 mutation, and DNA methylation profiling consistent with IRMT with malignant progression. The tumor was surgically resected, and pathological examination of the resected specimen confirmed a minor conventional IRMT component. Furthermore, infiltration of CD163-positive histiocytes was prominent, and fluorescence in situ hybridization analysis revealed two red signals (COL1A1 on chromosome 17) and four green signals (PDGFB on chromosome 22) in most tumor cells. Collectively, these histopathological, immunohistochemical, cytogenetic, and epigenetic findings established a final diagnosis of IRMT with malignant progression. Conclusions Given the small tumor size, chemotherapy and radiotherapy were not administered. Nevertheless, the long-term behavior of IRMT with malignant progression remains unclear; thus, careful follow-up is warranted.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP23K06438)
- Takeda Science Foundation
- The Foundation for Promotion of Cancer Research
- Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
This publication has 36 references indexed in Scilit:
- Histiocyte-rich rhabdomyoblastic tumor easily misdiagnosed as rhabdomyosarcoma: a case reportDiscover Oncology, 2025
- Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcomaGenes, Chromosomes and Cancer, 2024
- Inflammatory Rhabdomyoblastic Tumor of the Posterior Pharyngeal WallJAMA Otolaryngology–Head & Neck Surgery, 2024
- Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of RhabdomyosarcomaLaboratory Investigation, 2023
- Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findingsGenes, Chromosomes and Cancer, 2022
- Inflammatory leiomyosarcoma of the head and neckInternational Journal of Surgery Case Reports, 2021
- Histiocyte-rich rhabdomyoblastic tumor of the trunkJAAD Case Reports, 2020
- Histiocyte-rich rhabdomyoblastic tumor: a report of two cases and a review of the differential diagnosesVirchows Archiv, 2020
- Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumorVirchows Archiv, 2020
- Rhabdomyosarcoma in Adults: New Perspectives on TherapyCurrent Treatment Options in Oncology, 2015